Other

Other long-term assets

Gilead Sciences Other long-term assets decreased by 21.6% to $308.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.2%, from $359.00M to $308.00M. Over 2 years (FY 2023 to FY 2025), Other long-term assets shows an upward trend with a 7.5% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2023
Last reportedQ1 2026May 7, 2026
Metric ID: other_other_equity_securities_without_readily_determinab_a6d699

Historical Data

10 periods
 Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$340.00M$359.00M$376.00M$382.00M$386.00M$359.00M$369.00M$393.00M$393.00M$308.00M
QoQ Change—+5.6%+4.7%+1.6%+1.0%-7.0%+2.8%+6.5%+0.0%-21.6%
YoY Change————+13.5%+0.0%-1.9%+2.9%+1.8%-14.2%
Range$308.00M – $393.00M
CAGR-4.3%
Avg YoY Growth+0.4%
Median YoY Growth+0.9%

Frequently Asked Questions

What is Gilead Sciences's other long-term assets?
Gilead Sciences (GILD) reported other long-term assets of $308.00M in Q1 2026.
How has Gilead Sciences's other long-term assets changed year-over-year?
Gilead Sciences's other long-term assets decreased by 14.2% year-over-year, from $359.00M to $308.00M.
What is the long-term trend for Gilead Sciences's other long-term assets?
Over 2 years (2023 to 2025), Gilead Sciences's other long-term assets has grown at a 7.5% compound annual growth rate (CAGR), from $340.00M to $393.00M.